Article
Polymorphisms in XPD gene could predict clinical outcome of platinum-based chemotherapy for non-small cell lung cancer patients: a meta-analysis of 24 studies.
PloS one - 1 Jan 2013
Qin Qin, Zhang Chi, Yang Xi, Zhu Hongcheng, Yang Baixia, Cai Jing, Cheng Hongyan, Ma Jianxin, Lu Jing, Zhan Liangliang, Liu Jia, Liu Zheming, Xu Liping, Sun Xinchen
Abstract excerpt
OBJECTIVE: Xeroderma pigmentosum group D (XPD) is an essential gene involved in the nucleotide excision repair (NER) pathway. Two commonly studied single nucleotide polymorphisms (SNPs) of XPD (Lys751Gln, A>C, rs13181; Asp312Asn, G>A, rs1799793) are implicated in the modulation of DNA repair capacity, thus related to the responses to platinum-based chemotherapy. Here we performed a meta-analysis to better...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
